Skip to content
10-Q

Quarterly Report

IOVANCE BIOTHERAPEUTICS, INC. IOVA

0001558370-25-010807

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 361.85M sh
Shares Diluted Q2 2025 · Jun 30, 2025 334.51K sh
Shares Diluted Q2 2025 · Jun 30, 2025 328.72K sh
Shares Diluted Q2 2025 · Jun 30, 2024 284.82K sh
Shares Diluted Q2 2025 · Jun 30, 2024 275.52K sh
Capex Q2 2025 · Jun 30, 2025 $13.67M
Capex Q2 2025 · Jun 30, 2024 $4.61M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$171.14M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$220.71M
Short Term Investments Q2 2025 · Jun 30, 2025 $168.71M
Short Term Investments Q2 2025 · Dec 31, 2024 $208.09M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $132.47M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $115.69M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $228.68M
Stockholders Equity Q2 2025 · Jun 30, 2025 $698.49M
Stockholders Equity Q2 2025 · Mar 31, 2025 $767.87M
Stockholders Equity Q2 2025 · Dec 31, 2024 $710.41M
Stockholders Equity Q2 2025 · Jun 30, 2024 $768.54M
Stockholders Equity Q2 2025 · Mar 31, 2024 $680.02M
Stockholders Equity Q2 2025 · Dec 31, 2023 $584.61M
Current Liabilities Q2 2025 · Jun 30, 2025 $129.16M
Current Liabilities Q2 2025 · Dec 31, 2024 $122.34M
Total Liabilities Q2 2025 · Jun 30, 2025 $208.95M
Total Liabilities Q2 2025 · Dec 31, 2024 $200.02M
Current Assets Q2 2025 · Jun 30, 2025 $422.5M
Current Assets Q2 2025 · Dec 31, 2024 $457.02M
Total Assets Q2 2025 · Jun 30, 2025 $907.44M
Total Assets Q2 2025 · Dec 31, 2024 $910.43M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.33
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.69
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.76
Eps Basic Q2 2025 · Jun 30, 2025 −$0.33
Eps Basic Q2 2025 · Jun 30, 2025 −$0.69
Eps Basic Q2 2025 · Jun 30, 2024 −$0.34
Eps Basic Q2 2025 · Jun 30, 2024 −$0.76
Sga Expense Q2 2025 · Jun 30, 2025 $37.7M
Sga Expense Q2 2025 · Jun 30, 2025 $81.62M
Sga Expense Q2 2025 · Jun 30, 2024 $39.57M
Sga Expense Q2 2025 · Jun 30, 2024 $70.96M
Rd Expense Q2 2025 · Jun 30, 2025 $79.36M
Rd Expense Q2 2025 · Jun 30, 2025 $156.24M
Rd Expense Q2 2025 · Jun 30, 2024 $62.08M
Rd Expense Q2 2025 · Jun 30, 2024 $141.87M
Net Income Q2 2025 · Jun 30, 2025 −$111.66M
Net Income Q2 2025 · Jun 30, 2025 −$227.82M
Net Income Q2 2025 · Jun 30, 2024 −$97.1M
Net Income Q2 2025 · Jun 30, 2024 −$210.08M
Operating Income Q2 2025 · Jun 30, 2025 −$113.77M
Operating Income Q2 2025 · Jun 30, 2025 −$235M
Operating Income Q2 2025 · Jun 30, 2024 −$101.91M
Operating Income Q2 2025 · Jun 30, 2024 −$219.64M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $56.66M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $106.41M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $31.37M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $38.63M
Revenue Q2 2025 · Jun 30, 2025 $59.95M
Revenue Q2 2025 · Jun 30, 2025 $109.28M
Revenue Q2 2025 · Sep 30, 2024 $31.11M
Revenue Q2 2025 · Jun 30, 2024 $31.11M
Revenue Q2 2025 · Jun 30, 2024 $31.82M